Valuation : Moderna, Inc.

Market Cap 5.81TCr 5TCr 4.7TCr 4.29TCr 8.02TCr 5,49600Cr 8.05TCr 56TCr 22TCr 2,81400Cr 22TCr 21TCr 8,96400Cr P/E 2026 *
-17.3x
P/E 2027 * -29.6x
Enterprise Value 5.45TCr 4.68TCr 4.4TCr 4.02TCr 7.52TCr 5,15000Cr 7.54TCr 52TCr 20TCr 2,63700Cr 20TCr 20TCr 8,40100Cr EV / Sales 2026 *
25.9x
EV / Sales 2027 * 22.9x
Free-Float
92.68%
Yield 2026 *
-
Yield 2027 * -
1 day-2.23%
1 week+5.48%
Current month+3.71%
1 month+170.24%
3 months+206.81%
6 months+177.13%
Current year+393.56%
1 week 138.09
Extreme 138.09
156.42
1 month 58.41
Extreme 58.41
176.66
Current year 29.81
Extreme 29.81
176.66
1 year 22.28
Extreme 22.28
176.66
3 years 22.28
Extreme 22.28
176.66
5 years 22.28
Extreme 22.28
464.85
10 years 11.54
Extreme 11.54
497.49
Manager TitleAgeSince
Chief Executive Officer 54 01/03/2011
Director of Finance/CFO 49 06/09/2022
President 50 01/11/2024
Director TitleAgeSince
Chairman 63 01/02/2012
Director/Board Member 54 01/03/2011
Director/Board Member 69 11/12/2019
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Exercice

General Counsel

15,793 0.0040%
01/09/26 Exercice

Chief Financial Officer

6,147 0.0015%
01/09/26 Exercice

Chairperson

23,055 0.0058%
Change 5-day change 1-year change 3-year change Capi.($)
-2.23%+5.48%+478.96%+34.47% 5.81TCr
-1.87%+4.22%+44.36%+1.14% 8.27TCr
-0.76%+0.50%-17.24%-36.14% 6.02TCr
+1.31%-1.35%-7.43%+30.97% 4.97TCr
-0.14%-2.86%+1.64%+155.53% 4.67TCr
-1.64%+1.07%+56.98%-16.26% 3.26TCr
-0.98%+1.91%+46.30%+100.59% 2.57TCr
-1.07%-5.77%-1.75%+191.93% 2.27TCr
-1.06%-3.47%+62.93%+106.61% 1.65TCr
-0.87%-10.62%-21.81%+776.89% 1.49TCr
Average -0.91%-0.45%+64.29%+134.57% 4.1TCr
Weighted average by Cap. -0.98%+0.74%+82.69%+69.50%

Financials

2026 *2027 *
Net sales 210.1Cr 180.68Cr 169.94Cr 155.13Cr 290.13Cr 20TCr 291.07Cr 2.01TCr 778.85Cr 10TCr 788.99Cr 771.74Cr 32TCr 243.77Cr 209.64Cr 197.18Cr 179.99Cr 336.63Cr 23TCr 337.72Cr 2.34TCr 903.69Cr 12TCr 915.46Cr 895.45Cr 38TCr
Net income -331.26Cr -284.88Cr -267.94Cr -244.59Cr -457.45Cr -31TCr -458.93Cr -3.18TCr -1.23TCr -16TCr -1.24TCr -1.22TCr -51TCr -194.48Cr -167.26Cr -157.31Cr -143.6Cr -268.57Cr -18TCr -269.44Cr -1.87TCr -720.97Cr -9.42TCr -730.37Cr -714.4Cr -30TCr
Net Debt -365.29Cr -314.15Cr -295.47Cr -269.72Cr -504.44Cr -35TCr -506.07Cr -3.5TCr -1.35TCr -18TCr -1.37TCr -1.34TCr -56TCr -216.92Cr -186.55Cr -175.46Cr -160.17Cr -299.55Cr -21TCr -300.52Cr -2.08TCr -804.14Cr -11TCr -814.62Cr -796.81Cr -33TCr
Logo Moderna, Inc.
Moderna, Inc. is a biotechnology company specialized in research and development of therapeutics and vaccines for cancer, infectious, autoimmune and cardiovascular diseases. Net sales break down by type of revenue as follows: - revenue from product sales (96.1%); - revenue from collaboration agreements (1.5%); - revenue from royalties and licensing (1.3%); - revenue from grants (1.1%). At the end of 2024, the group's portfolio comprises 37 products in clinical development, of which 10 in phase I, 18 in phase II and 9 in phase III, 3 products in preclinical development, and 4 products in commercial phase. Net sales are distributed geographically as follows: the United States (55.1%), Europe (18.5%) and other (26.4%).
Employees
4,700
Date Price Change Volume
04/26/04 $145.55 -2.23% 1,49,66,547
03/26/03 $148.87 -1.29% 1,32,90,379
02/26/02 $150.81 -2.24% 1,65,63,188
01/26/01 $154.27 +9.93% 2,58,31,743
31/26/31 $140.34 +1.70% 1,85,70,704
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
145.55USD
Average target price
116.50USD
Spread / Average Target
-19.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MRNA Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!